Compare FUSE & MDAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FUSE | MDAI |
|---|---|---|
| Founded | 2013 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 43.2M | 48.8M |
| IPO Year | N/A | N/A |
| Metric | FUSE | MDAI |
|---|---|---|
| Price | $1.73 | $1.54 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $3.25 |
| AVG Volume (30 Days) | ★ 10.9M | 350.2K |
| Earning Date | 06-05-2026 | 03-26-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $7,949,000.00 | ★ $23,168,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 6.87 | N/A |
| 52 Week Low | $1.45 | $1.04 |
| 52 Week High | $25.00 | $3.21 |
| Indicator | FUSE | MDAI |
|---|---|---|
| Relative Strength Index (RSI) | 45.91 | 43.24 |
| Support Level | $1.65 | $1.47 |
| Resistance Level | $2.13 | $1.63 |
| Average True Range (ATR) | 0.35 | 0.13 |
| MACD | -0.00 | -0.03 |
| Stochastic Oscillator | 6.84 | 13.40 |
Fusemachines Inc is a provider of enterprise AI products and solutions. The company provides good quality AI education in underserved communities and helping organizations achieve their full potential with AI. The products of the company include AI Studio, Answer Gen, GenAI Engines, and others.
Spectral AI Inc is an AI company, focused on predictive medical diagnostics. Spectral is devoting substantially all of its efforts towards the research and development of its DeepView System, an internally developed MSI device that has designated FDA BDD status. Its DeepView System uses proprietary algorithms to distinguish between damaged and healthy human tissue invisible to the naked eye, providing Day One healing assessments in seconds. The Company's output is specifically engineered to allow the physician to make a more accurate, timely, and informed decision regarding the treatment of the patient's wound.